Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban

NCT02403596 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

231

Enrollment

OTHER

Sponsor class

Conditions

Blood Loss After a Total Hip Replacement

Interventions

DRUG: Exacyl®
OTHER: Placebo of Exacyl®

Sponsor

University Hospital, Brest

Collaborators

[object Object]